Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

329 ARTÍCULOS , VIENDO DEL 61 AL 75

An open-label, nonplacebo-controlled study on Cistanche tubulosa glycoside capsules (Memoregain(®)) for treating moderate Alzheimer's Disease

Guo Q, Zhou Y, Wang CJ, Huang YM, Lee YT, Su MH, Lu J.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):363-70. doi: 10.1177/1533317513488907. Epub 2013 May 17.

Prediction models for assessing long-term outcome in Alzheimer's disease: a review

Wattmo C.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):440-9. doi: 10.1177/1533317513488916. Epub 2013 May 20.

[Effectiveness and limitation of newly approved drugs for Alzheimer's disease]

Hattori H.

Seishin Shinkeigaku Zasshi. 2013;115(1):22-31.

Drug development in dementia

Cunningham EL, Passmore AP.

Maturitas. 2013 Nov;76(3):260-6. doi: 10.1016/j.maturitas.2013.04.013. Epub 2013 May 23.

Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease

Gao J, Inagaki Y, Li X, Kokudo N, Tang W.

Drug Discov Ther. 2013 Apr;7(2):46-57.

Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease

Igeta H, Suzuki Y, Motegi T, Sasaki A, Yokoyama Y, Someya T.

Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):680.e9-10. doi: 10.1016/j.genhosppsych.2013.04.007. Epub 2013 Jun 2.

Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia

Bahar-Fuchs A, Clare L, Woods B.

Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD003260. doi: 10.1002/14651858.CD003260.pub2.

Nutritional approaches in the risk reduction and management of Alzheimer's disease

Mi W, van Wijk N, Cansev M, Sijben JW, Kamphuis PJ.

Nutrition. 2013 Sep;29(9):1080-9. doi: 10.1016/j.nut.2013.01.024. Epub 2013 Jun 4.

Evaluation of the efficacy of a cognitive rehabilitation treatment on a group of Alzheimer's patients with moderate cognitive impairment: a pilot study

Salotti P, De Sanctis B, Clementi A, Fernandez Ferreira M, De Silvestris T.

Aging Clin Exp Res. 2013 Aug;25(4):403-9. doi: 10.1007/s40520-013-0062-5. Epub 2013 Jun 13.

One-year repeated cycles of cognitive training (CT) for Alzheimer's disease

Bergamaschi S, Arcara G, Calza A, Villani D, Orgeta V, Mondini S.

Aging Clin Exp Res. 2013 Aug;25(4):421-6. doi: 10.1007/s40520-013-0065-2. Epub 2013 Jun 20.

Cholinesterase inhibitors in vascular cognitive impairment

Massoud F.

Can J Neurol Sci. 2013 Jul;40(4):446-7. doi: 10.1017/s0317167100014487.

Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

Ashby EL, Kehoe PG.

Expert Opin Investig Drugs. 2013 Oct;22(10):1229-42. doi: 10.1517/13543784.2013.812631. Epub 2013 Jun 26.

Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?

Corbett A, Ballard C.

Expert Opin Investig Drugs. 2013 Aug;22(8):941-3. doi: 10.1517/13543784.2013.815723. Epub 2013 Jul 1.

Caregiver burden and psychosocial services in patients with early and late onset Alzheimer's disease

Grønning H, Kristiansen S, Dyre D, Rahmani A, Gyllenborg J, Høgh P.

Dan Med J. 2013 Jul;60(7):A4649.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias